Genomma Lab Internacional, S.A.B. de C.V. Stock
Stocks
LAB B
MX01LA010006
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.78 MXN | -2.12% |
|
-3.52% | -17.38% |
| Market Cap | 14.41B 829M 718M 662M 619M 1.15B 78.99B 1.18B 7.86B 3.05B 38.25B 3.11B 3.05B 133B | P/E Ratio 2026 * |
6.4x | P/E Ratio 2027 * | 6.66x |
|---|---|---|---|---|---|
| Enterprise Value | 18.12B 1.04B 902M 832M 778M 1.45B 99.28B 1.48B 9.88B 3.83B 48.08B 3.91B 3.83B 167B | EV / Sales 2026 * |
0.99x | EV / Sales 2027 * | 0.93x |
| Free-Float |
69.07% | Yield 2026 * |
5.41% | Yield 2027 * | 7.43% |
Last Transcript: Genomma Lab Internacional, S.A.B. de C.V.
| 1 day | -2.12% | ||
| 1 week | -3.52% | ||
| Current month | -7.51% | ||
| 1 month | -13.52% | ||
| 3 months | -16.45% | ||
| 6 months | -22.33% | ||
| Current year | -17.38% |
| 1 week | 14.66 |  | 15.4 |
| 1 month | 14.66 | | 16.89 |
| Current year | 14.66 | | 19.48 |
| 1 year | 14.66 | | 23.6 |
| 3 years | 12.39 | | 29.18 |
| 5 years | 12.39 | | 29.18 |
| 10 years | 11.1 | | 29.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marco Sparvieri
CEO | Chief Executive Officer | - | 2023-04-11 |
| Director of Finance/CFO | - | 2015-11-30 | |
| Investor Relations Contact | - | 2019-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 1996-10-29 | |
Juan Alonso
BRD | Director/Board Member | - | 2010-07-05 |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.12% | -3.52% | -32.05% | +0.96% | 829M | |
| +2.45% | +3.15% | +43.54% | +160.64% | 1,013B | |
| +0.61% | +5.03% | +54.35% | +49.87% | 574B | |
| +0.46% | +0.27% | +17.78% | +63.76% | 397B | |
| -0.37% | +4.97% | +21.24% | +15.95% | 324B | |
| +0.85% | +0.18% | +24.50% | +14.78% | 280B | |
| +2.10% | +4.92% | +25.30% | +33.80% | 273B | |
| +3.46% | +0.88% | +19.48% | +60.40% | 182B | |
| -0.19% | -0.46% | -45.32% | -48.35% | 194B | |
| +3.82% | -2.67% | +15.03% | +61.48% | 151B | |
| Average | +1.08% | +2.02% | +14.38% | +41.33% | 338.95B | |
| Weighted average by Cap. | +1.42% | +3.99% | +29.51% | +72.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 18.32B 1.05B 912M 841M 787M 1.47B 100B 1.5B 9.99B 3.87B 48.62B 3.96B 3.87B 169B | 19.24B 1.11B 958M 883M 826M 1.54B 105B 1.58B 10.49B 4.07B 51.05B 4.15B 4.06B 178B |
| Net income | 2.14B 123M 106M 98.06M 91.74M 171M 11.71B 175M 1.16B 452M 5.67B 461M 451M 19.72B | 2.25B 129M 112M 103M 96.64M 180M 12.33B 184M 1.23B 476M 5.97B 486M 476M 20.77B |
| Net Debt | 3.7B 213M 184M 170M 159M 297M 20.29B 303M 2.02B 783M 9.83B 800M 782M 34.17B | 3.44B 198M 171M 158M 148M 276M 18.85B 282M 1.88B 727M 9.13B 743M 727M 31.74B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-10 | 14.78 $ | -2.12% | 3,712,730 |
| 26-06-09 | 15.10 $ | +1.14% | 3,854,865 |
| 26-06-08 | 14.93 $ | +1.50% | 4,215,708 |
| 26-06-05 | 14.71 $ | -4.04% | 3,899,161 |
| 26-06-04 | 15.33 $ | +0.07% | 3,569,130 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LAB B Stock
Select your edition
All financial news and data tailored to specific country editions
